{
  "system_prompt": "You are a buy-side equity PM constructing a long-only portfolio from scored candidates.\nRules:\n- Select exactly 20 stocks from the scored candidates provided.\n- Assign weights between 2% and 10% per stock (0.02 to 0.10).\n- Weights must sum to exactly 100% (1.0).\n- Diversify across sectors and industries (respect sector_cap and industry_cap constraints).\n- Prioritize stocks with higher composite scores, but ensure diversification.\n- Consider sector/industry balance and avoid over-concentration.\n- Output must be strict JSON.",
  "user_prompt": "Portfolio Construction Task:\n\n      Investment Horizon: Today to 2026-05-15 (150 days remaining)\n\n      Constraints:\n      - Select EXACTLY 20 stocks\n      - Weight per stock: 2% to 10% (0.02 to 0.10)\n      - Total weight must sum to EXACTLY 100% (1.0)\n      - Sector cap: 35% (no single sector > 35%)\n      - Industry cap: 20% (no single industry > 20%)\n      - Long-only portfolio (no short positions)\n\n      Scored Candidates (sorted by composite score, showing top 40):\n        ADBE: score=0.686, sector=Information Technology, sentiment=bullish, price=$351.15\n  News: Adobe Inc. (NASDAQ: ADBE) has recently experienced a rebound, climbing approximately 5.1% over the past week, although it remains down about 19.2% year-to-date. Analysts from Bernstein and Oppenheimer have reiterated Buy ratings, with Bernstein slightly lowering its price target from $508 to $506. However, KeyBanc Capital Markets has downgraded Adobe to Underweight, citing rising risks related to artificial intelligence and valuation concerns in the enterprise software sector. Overall, while short-term momentum is positive, longer-term growth prospects appear uncertain.\nGOOGL: score=0.655, sector=Communication Services, sentiment=bullish, price=$308.22, theme=AI Infrastructure Buildout\n  News: Alphabet's stock (GOOGL) has experienced a significant surge of 63% in 2025, reaching a market capitalization of $3.7 trillion, reflecting strong investor confidence amid ongoing advancements in artificial intelligence. In a notable business development, TotalEnergies has signed a 21-year power purchase agreement with Google to supply renewable energy for its data centers in Malaysia, further supporting its sustainability initiatives. Despite these positive trends, some analysts have raised concerns about potential overvaluation and a deceleration in search ad revenue, suggesting a cautious approach for investors.\nMRK: score=0.640, sector=Health Care, sentiment=bullish, price=$100.26\n  News: Merck (MRK) is projected to achieve mid-single-digit revenue growth by fiscal 2026, bolstered by a positive CHMP opinion for the expanded use of its drug Winrevair in treating pulmonary arterial hypertension (PAH). Additionally, the company announced an increase in its upcoming dividend to $0.85, reflecting its commitment to returning value to shareholders. Despite broader industry challenges, including potential impacts from a biotech bill affecting patent protections, Merck's recent developments position it favorably in the market.\nV: score=0.609, sector=Financials, sentiment=bullish, price=$346.89\n  News: Visa Inc. (NYSE:V) has recently seen positive analyst sentiment, with Evercore ISI raising its price target to $380 and BofA upgrading the stock to Buy with a $382 target, citing attractive return potential. The company is also expanding its services by launching a Stablecoins Advisory Practice to assist banks and fintechs in navigating the growing stablecoin market, which has surpassed $300 billion. Additionally, Visa is integrating its payment solutions with MassPay for faster B2B payouts, while facing challenges from merchants opposing a proposed settlement over card fees. Overall, Visa's strong performance in digital payments and cross-border transactions continues to bolster its market outlook.\nNDAQ: score=0.585, sector=Financial Services, sentiment=bullish, price=$92.93, theme=Energy Transition and Sustainability\n  News: Nasdaq Inc. is seeking SEC approval to implement near round-the-clock trading, reflecting a growing demand from global investors for more flexible trading hours. This initiative comes as Nasdaq shows improved technical performance, indicated by a recent Relative Strength Rating upgrade. Additionally, the company has announced cash tender offers for its outstanding debt securities, signaling proactive financial management amid a strong stock performance, with a notable 20.8% year-to-date increase. However, some analysts question whether the stock's current price around $93 leaves limited upside after a significant five-year surge of 133%.\nMA: score=0.584, sector=Financials, sentiment=bullish, price=$569.13\n  News: Mastercard (NYSE:MA) has recently seen a positive shift in its stock outlook, with Evercore ISI raising its price target to $610 and HSBC upgrading its rating from Hold to Buy. The company announced a substantial $14 billion share repurchase plan and a 14% increase in its quarterly dividend, reflecting strong cash generation and a commitment to shareholder returns. Additionally, Mastercard is expanding its digital payment partnerships, enhancing its position in the growing ecommerce sector. Despite these developments, the stock has been relatively stagnant over the past six months, underperforming compared to the S&P 500.\nBKNG: score=0.580, sector=Consumer Discretionary, sentiment=bullish, price=$5457.7\n  News: Recent commentary from Jim Cramer highlights Booking Holdings Inc. (BKNG) as a 'superior operator' compared to Expedia, despite the latter being viewed as the cheaper stock. BKNG has shown resilience with a notable 15% gain since its November low, indicating strong recovery potential. As the travel sector prepares for the year-end holiday season, Booking's competitive positioning remains crucial amidst evolving market dynamics and consumer preferences. Overall, BKNG's performance and strategic advantages suggest it may be a solid investment choice in the current climate.\nJPM: score=0.515, sector=Financials, sentiment=bullish, price=$320.02\n  News: JPMorgan Chase has announced significant growth plans for 2026, including the launch of a tokenized money market fund tied to the Ethereum blockchain, reflecting its deeper commitment to the crypto space. The bank also declared dividends on its Series CC preferred stock and is actively financing a $7.4 billion zinc-mining deal as part of its national security funding initiative. Additionally, financial stocks, including JPMorgan, saw gains in late trading, indicating positive market sentiment. These developments highlight JPMorgan's strategic focus on innovation and growth in both traditional and emerging sectors.\nAMGN: score=0.508, sector=Biotechnology, sentiment=bullish, price=$325.31, theme=Healthcare and Biotech Innovation\n  News: Amgen recently received FDA approval for UPLIZNA, a CD19-targeted therapy for generalized myasthenia gravis, enhancing its portfolio in rare diseases. The stock has shown resilience, closing at $325.31 with a 2.38% increase, even as broader market indices experienced fluctuations. Additionally, Amgen announced a dividend increase to $2.52, reflecting its commitment to returning value to shareholders. These developments position Amgen favorably for long-term investment considerations.\nTROW: score=0.468, sector=Financials, sentiment=neutral, price=$103.62\n  News: T. Rowe Price has recently launched its first joint model portfolios in collaboration with Goldman Sachs, targeting mass affluent and high-net-worth investors, marking a significant step in their strategic alliance. However, the firm reported $8 billion in net outflows for November, alongside a slight decline in assets under management, raising concerns about its fee base and long-term business outlook. Additionally, T. Rowe Price has introduced new active equity ETFs, waiving fees for the first 13 months to attract investors amidst a competitive market environment. Despite these challenges, T. Rowe Price's stock has shown resilience, recently closing at $104.96, reflecting a 1.35% increase in a fluctuating market.\nMETA: score=0.462, sector=Communication Services, sentiment=bullish, price=$647.51, theme=Regulatory Changes in Technology and Trade\n  News: Meta Platforms is gaining attention from Wall Street analysts, with expectations of a 47% upside following recent earnings, suggesting that its investments in artificial intelligence are yielding positive results. Additionally, the company has joined other tech giants in obtaining authorizations to sell wholesale power, indicating a strategic shift towards energy trading. Notably, billionaire investor Philippe Laffont has increased his stake in Meta, making it the largest position in his portfolio, further highlighting confidence in the company's future prospects.\nPG: score=0.460, sector=Consumer Staples, sentiment=bullish, price=$145.13, theme=Consumer Resilience Amid Economic Uncertainty\n  News: Procter & Gamble (PG) has been identified as one of the worst performers in the Dow Jones Industrial Average for 2025, alongside other major companies. Despite this, analysts suggest that PG's current share price and over 3% dividend yield present a compelling opportunity for long-term investors. Additionally, Jim Cramer emphasized the potential for recovery in PG, advising patience for investors. Recent partnerships, such as with USA Hockey, may also enhance brand visibility and engagement moving forward.\nNVDA: score=0.459, sector=Information Technology, sentiment=bullish, price=$176.29, theme=Private Market Growth and Investment Opportunities\n  News: Nvidia continues to be a key player in the tech sector, with its stock being highlighted among major movers in the Dow Jones Futures. Analysts are optimistic about Nvidia's growth potential, particularly in relation to AI spending trends. The company's future performance is closely tied to the broader market dynamics and the spending plans of its clients. Additionally, Nasdaq's proposal to extend trading hours could enhance liquidity and investor access to Nvidia and other tech stocks.\nKO: score=0.448, sector=Consumer Staples, sentiment=bullish, price=$70.97, theme=Consumer Resilience Amid Economic Uncertainty\n  News: Coca-Cola (KO) has announced that Henrique Braun will succeed James Quincey as CEO on March 31, 2026, a transition that investors view positively, reflected in a 14% year-to-date share price increase. The company is also exploring innovation opportunities and potential bolt-on mergers and acquisitions, contributing to its status as one of the best-performing Dow stocks in 2025. Additionally, Coca-Cola is in discussions with TDR Capital regarding the proposed sale of Costa Coffee, indicating ongoing strategic maneuvers in its portfolio. Overall, these developments suggest a stable outlook for the company as it prepares for leadership changes and market expansion.\nQCOM: score=0.441, sector=Information Technology, sentiment=neutral, price=$179.26\n  News: Qualcomm (QCOM) is currently viewed as a strong buy, with analysts projecting a 23% upside potential driven by robust earnings and growth in automotive and AI sectors. However, the stock recently experienced a decline of 1.64%, closing at $178.29, amid broader market concerns regarding AI margins and competition in the chip industry. Additionally, Qualcomm is expanding its footprint in the AI video intelligence market through a partnership with CP PLUS, which could further enhance its growth prospects. Overall, while there are challenges, Qualcomm's strategic moves in high-growth areas may position it favorably in the long term.\nCSCO: score=0.411, sector=Information Technology, sentiment=bullish, price=$78.25, theme=Regulatory Changes in Technology and Trade\n  News: Cisco Systems (CSCO) has seen a significant share price increase of approximately 37% over the past year, recently reaching a record high of $80.25, the first such peak in over 25 years. The company is benefiting from strong demand in AI infrastructure, prompting an upward revision of its full-year guidance. Additionally, Cisco's recent filing for employee stock ownership plan offerings indicates ongoing confidence in its growth trajectory. Analysts are reassessing Cisco's valuation in light of its robust performance and market position amid rising AI-related opportunities.\nNFLX: score=0.406, sector=Communication Services, sentiment=bullish, price=$93.77, theme=Regulatory Changes in Technology and Trade\n  News: Netflix is set to announce its fourth quarter 2025 financial results on January 20, 2026, amid ongoing discussions regarding its $82.7 billion bid for Warner Bros., which faces competition from a hostile $108 billion offer from Paramount. Co-CEOs Greg Peters and Ted Sarandos have reassured staff and investors of Netflix's commitment to theatrical releases despite concerns about the future of its movie business. The streaming giant's stock has seen a significant increase of 701% over the past decade, indicating strong long-term performance.\nISRG: score=0.404, sector=Healthcare, sentiment=bullish, price=$559.52, theme=Healthcare and Biotech Innovation\n  News: Intuitive Surgical (ISRG) has received FDA clearance to expand the use of its da Vinci SP robot for three new general surgeries, enhancing its position in minimally invasive care. Despite a muted 1-year return of 2.6%, the stock has shown strong long-term performance with gains of 113.7% and 105.9% over the past 3 and 5 years, respectively. Investor interest remains high, particularly as the company navigates challenges in the bariatric surgery market due to GLP-1 drug impacts, while also capitalizing on growth in general surgery. Overall, analysts are optimistic about ISRG's potential as it continues to expand its offerings.\nAAPL: score=0.397, sector=Information Technology, sentiment=neutral, price=$274.11, theme=Regulatory Changes in Technology and Trade\n  News: Apple Inc. (AAPL) recently closed at $274.11, reflecting a 1.5% decline, which was more pronounced than the broader market's movements. This comes amid rising chip costs that are expected to negatively impact global smartphone shipments by 2.1% in 2026, potentially affecting demand for Apple's products. Additionally, Nasdaq plans to submit paperwork for near round-the-clock trading, which could enhance trading opportunities for AAPL and other tech stocks. These developments highlight the challenges and opportunities facing Apple in a competitive and evolving market landscape.\nMSFT: score=0.397, sector=Information Technology, sentiment=bullish, price=$474.82, theme=Regulatory Changes in Technology and Trade\n  News: Microsoft Corporation (NASDAQ:MSFT) has faced recent stock underperformance attributed to concerns regarding its relationship with OpenAI following the Oracle/OpenAI deal. However, Jefferies analysts maintain a positive outlook, highlighting Microsoft's potential benefits from OpenAI's enterprise expansion in 2026 and reiterating a Buy rating. Additionally, a recent sell-off in the stock is viewed as a strong buying opportunity, particularly in light of increased capital expenditures driven by AI infrastructure. Overall, the market sentiment remains cautiously optimistic about Microsoft's long-term growth prospects.\nMCD: score=0.386, sector=Consumer Discretionary, sentiment=neutral, price=$318.73\n  News: McDonald's Corporation (NYSE:MCD) continues to perform well, being recognized as one of the best-performing Dow stocks in 2025, with Barclays maintaining a Buy rating and a price target of $358. However, the company is facing challenges, including the recent sale of $12 million in shares by insiders, which may indicate hesitancy about future performance. Additionally, McDonald's is closing locations as part of a broader trend among fast-food chains responding to rising costs and changing consumer habits. Despite these challenges, the brand's value focus and digital strengths remain significant advantages over competitors like Chipotle.\nPFE: score=0.378, sector=Health Care, sentiment=neutral, price=$26.43\n  News: Pfizer (PFE) continues to attract investor interest, as indicated by increased searches on financial platforms, although Bank of America Securities has maintained a neutral recommendation on the stock. In a notable development, Adaptive Biotechnologies announced two licensing agreements with Pfizer aimed at advancing research in immunology, which could enhance Pfizer's portfolio in this area. Additionally, the ongoing collaboration with IDEAYA Biosciences on a pivotal trial for metastatic uveal melanoma highlights Pfizer's involvement in innovative cancer treatments. Overall, these developments suggest a focus on strategic partnerships and research advancements as key factors influencing Pfizer's market position.\nRTX: score=0.373, sector=Industrials, sentiment=bullish, price=$182.11, theme=Geopolitical Tensions and Market Volatility\n  News: RTX has garnered attention as a key player in the aerospace and defense sector, particularly following Germany's recent $3.5 billion missile purchase, which could yield $350 million in profit for the company. Citigroup has initiated coverage of RTX with a 'Buy' recommendation, indicating positive sentiment among analysts. However, the stock's performance has been mixed compared to its peers, prompting investors to weigh their options carefully. Additionally, the broader industrial sector appears overvalued, which may impact investment decisions moving forward.\nPLTR: score=0.366, sector=Information Technology, sentiment=neutral, price=$183.25, theme=Private Market Growth and Investment Opportunities\n  News: Palantir Technologies Inc. (PLTR) recently renewed its three-year contract with France's domestic intelligence agency, DGSI, marking over a decade of partnership. The company has seen a significant stock performance increase of 146% year-to-date, despite broader market concerns about an AI bubble affecting technology stocks. CEO Alex Karp criticized the accountability of corporate leaders in his recent remarks, emphasizing Palantir's commitment to absorbing risks associated with its operations. As the market navigates volatility, PLTR's strong contract renewals and focus on innovation position it as a notable player in the tech sector.\nABBV: score=0.362, sector=Health Care, sentiment=bullish, price=$227.45\n  News: AbbVie (ABBV) recently experienced a 1.85% increase in stock price, closing at $227.45, amidst a generally declining market. The stock has gained momentum following an upgrade to 'Buy' by HSBC, driven by strong earnings, increased guidance, and a dividend hike, contributing to a year-to-date gain of 24.45%. However, analysts at BofA Securities caution that AbbVie's growth potential may be limited in 2026 due to a light pipeline. Additionally, positive sentiment in the options market suggests potential bullish trades for ABBV stock.\nVZ: score=0.356, sector=Communication Services, sentiment=neutral, price=$40.8\n  News: Verizon (NYSE: VZ) has recently reported its Q3 results, highlighting a disciplined approach to wireless pricing and a focus on customer service under new leadership. However, concerns have emerged regarding the company's returns on capital, indicating a potential slowdown in growth. Meanwhile, AT&T is pursuing aggressive expansion through a significant spectrum acquisition and the rollout of its 5G network, contrasting with Verizon's more conservative strategy. The telecom sector is facing increased competition and challenges, prompting analysts to adopt a cautious outlook on the industry as a whole.\nMMM: score=0.348, sector=Industrials, sentiment=bullish, price=$165.7\n  News: 3M Company (NYSE:MMM) has seen a significant rebound in its stock, with a 90% increase and improved sales and profits, prompting analysts like Barclays to raise their price target from $180 to $190 while maintaining an Overweight rating. However, Deutsche Bank recently downgraded the stock from Buy to Hold, citing that it has performed well since their last upgrade. Despite ongoing concerns regarding PFAS liabilities, the market sentiment appears cautiously optimistic about 3M's operational turnaround and future growth prospects. Overall, analysts are divided, with some viewing the stock as a buy and others recommending a more cautious approach.\nJNJ: score=0.341, sector=Health Care, sentiment=neutral, price=$214.17\n  News: Johnson & Johnson (JNJ) has received FDA approval for the expanded use of its prostate cancer drug Akeega, which could enhance its market potential following strong phase III trial results. Despite this positive development, analysts from BofA Securities maintain a neutral recommendation, citing the company's stable but modest growth outlook. JNJ is scheduled to host an investor conference call on January 21, 2026, to discuss its fourth-quarter results, as it remains one of the top performers in the Dow Jones Industrial Average for 2025.\nNTRS: score=0.332, sector=Financials, sentiment=neutral, price=$139.62\n  News: Northern Trust Corporation (NTRS) has recently decreased its prime rate from 7.00% to 6.75%, aiming to enhance its lending strategy and remain competitive among sophisticated clients. The company has also reported significant business momentum, securing over 100 asset servicing mandates worth more than $385 billion in 2025. Despite outperforming the S&P 500 over the past year, analysts express caution regarding its future prospects, especially as the stock has seen a substantial rise of 28.3% year-to-date. Investors are now evaluating whether the current stock price reflects its growth potential after a notable rally.\nPEP: score=0.331, sector=Consumer Staples, sentiment=bullish, price=$151.22\n  News: PepsiCo (PEP) is currently collaborating with an activist investor to enhance profitability, while also preparing to streamline its brand portfolio, which has garnered a 'buy' recommendation from JPMorgan Chase. The company is recognized as a strong dividend aristocrat, appealing to investors seeking reliable income streams, especially in retirement portfolios. Recent trading has shown resilience, with PEP's stock price rising despite broader market declines, indicating positive investor sentiment as it heads into 2026.\nLMT: score=0.330, sector=Industrials, sentiment=bullish, price=$484.42, theme=Geopolitical Tensions and Market Volatility\n  News: Lockheed Martin (NYSE: LMT) has recently completed production of F-16 Block 70 aircraft for Bulgaria and Slovakia, enhancing its position in the defense sector. Despite a modest share price increase of over 10% recently, there have been no new Buy ratings from analysts, indicating a cautious market sentiment. Additionally, the aerospace landscape is poised for disruption with SpaceX's upcoming IPO, projected to be valued significantly higher than Lockheed and its competitors, which could impact investor interest in LMT moving forward.\nHD: score=0.327, sector=Consumer Discretionary, sentiment=neutral, price=$356.99\n  News: Home Depot's stock narrative is shifting as analysts have lowered their fair value estimate from $403 to $399, reflecting concerns over softer revenue growth and increased discount rates. The company is expected to face challenges in Q4 due to declining storm-driven demand and tough year-over-year comparisons. Despite a year-to-date decline of 7.4%, the stock has shown resilience over the longer term, with a 20% increase over three years. Notably, Jim Cramer believes the stock is undervalued and trusts the management's ability to navigate the current economic landscape.\nLOW: score=0.321, sector=Consumer Discretionary, sentiment=bullish, price=$248.78\n  News: Lowe's Companies, Inc. (NYSE:LOW) continues to attract significant interest from institutional investors, who hold 79% of its shares, indicating strong confidence in the company's performance. Recent reports suggest that Lowe's is being closely monitored by investors, especially as the home improvement sector faces challenges, including softening demand and competition from Home Depot. Despite these pressures, Lowe's remains a favored stock among analysts, with ongoing product innovations aimed at enhancing customer engagement during the holiday season.\nGILD: score=0.307, sector=Health Care, sentiment=bullish, price=$119.78\n  News: Gilead Sciences (GILD) recently announced positive topline results from its Phase 3 ARTISTRY-2 trial, demonstrating the efficacy of its investigational single-tablet regimen for HIV treatment. Meanwhile, a setback occurred as Arcus Biosciences discontinued a partnered study with Gilead, impacting investor sentiment. Additionally, new findings regarding Gilead's CAR T therapy, Yescarta, suggest potential earlier use in treatment pathways for lymphoma, which could enhance its market position. Overall, these developments indicate both promising advancements and challenges for Gilead's product pipeline.\nMS: score=0.298, sector=Financials, sentiment=bullish, price=$177.79\n  News: Morgan Stanley (MS) is experiencing renewed investor interest following recent analyst upgrades and positive earnings estimates, contributing to an 8% share price increase over the past month and a total shareholder return of nearly 45% over the past year. The firm has also made a strategic acquisition of a $211 million last-mile delivery facility near LAX, which is expected to enhance its real estate investment portfolio. Additionally, a recent Fed rate cut is anticipated to boost Morgan Stanley's investment banking fee growth amid rising deal-making activity. Overall, the financial sector, including MS, is poised for potential outperformance as rising Treasury rates create new investment opportunities.\nUNH: score=0.282, sector=Health Care, sentiment=bullish, price=$341.1\n  News: UnitedHealth Group (UNH) has faced challenges in 2025, being one of the worst performers in the Dow Jones Industrial Average. Despite this, the stock has shown resilience, recently increasing by 6.2% amid a rally in health insurance stocks due to potential extensions of Affordable Care Act subsidies. The company is set to release its full-year financial results on January 27, 2026, which may provide further insights into its growth prospects. Analysts remain optimistic, with some rating UNH as a Strong Buy and projecting a 19% upside based on strategic changes and future growth potential.\nCRWD: score=0.280, sector=Information Technology, sentiment=bullish, price=$487.47, theme=Private Market Growth and Investment Opportunities\n  News: CrowdStrike (CRWD) has recently launched its Falcon AI Detection and Response platform, enhancing its capabilities to secure AI interactions, which positions it favorably in the competitive cybersecurity landscape. Despite a 5.2% gain over the last six months, the stock has underperformed compared to the S&P 500, raising questions among investors about its future potential. Additionally, TimesSquare Capital Management has sold its holdings in CRWD, citing market cap considerations, while the stock remains up 45.3% year-to-date. Overall, while CRWD continues to innovate, its recent performance and external market factors may influence investment decisions.\nPYPL: score=0.266, sector=Financials, sentiment=bullish, price=$60.74\n  News: PayPal has formally applied for a state-chartered bank license in Utah to establish PayPal Bank, aiming to enhance its lending and deposit services, particularly for small businesses. This move aligns with a broader trend among fintech firms seeking bank charters to expand their financial offerings. Despite these strategic developments, PayPal's stock has recently experienced a decline, closing at $60.74, down 1.49% from the previous day.\nBMY: score=0.244, sector=Health Care, sentiment=bullish, price=$54.29\n  News: Bristol Myers Squibb (BMY) shares rose 3.7% following a rating upgrade from Bank of America, which shifted its outlook from 'Neutral' to 'Buy' and raised the price target, highlighting the company's favorable risk/reward profile ahead of key pipeline catalysts in 2026. The stock has gained 13.1% over the past three months, driven by increased demand for its drugs like Opdivo and Reblozyl, despite facing generic competition on legacy products. Additionally, the company announced a 1.6% dividend increase, reflecting confidence in its ongoing oncology pipeline and recent FDA approvals. Overall, BMY appears well-positioned in the healthcare sector, which saw gains amid broader market declines.\nAMZN: score=0.216, sector=Consumer Discretionary, sentiment=bullish, price=$222.54, theme=AI Infrastructure Buildout\n  News: Amazon.com Inc. (AMZN) continues to be highlighted as a top tech stock, having increased over 230,000% since its IPO nearly 30 years ago, indicating its potential for long-term wealth building. Additionally, Nasdaq is planning to submit paperwork to the SEC for near round-the-clock trading of U.S. stocks, which could enhance liquidity and investor access to AMZN and other major tech equities. This move reflects growing demand for continuous trading in U.S. markets, potentially benefiting companies like Amazon as global interest in U.S. equities rises.\n\n      Instructions:\n      1. Select the best 20 stocks considering:\n         - Composite score (higher is better)\n         - Sector diversification (aim for 3-6 sectors, none > 35%)\n         - Industry diversification (none > 20%)\n         - Sentiment alignment (prefer bullish/neutral over bearish)\n         - Theme exposure (balance themed and non-themed stocks)\n\n      2. Assign weights:\n         - Higher scores can get higher weights (up to 10%)\n         - Lower scores should get lower weights (minimum 2%)\n         - Ensure weights sum to exactly 1.0 (100%)\n\n      3. Validate:\n         - Exactly 20 holdings\n         - Each weight between 0.02 and 0.1\n         - Total weight = 1.0\n         - No sector exceeds 35%\n         - No industry exceeds 20%\n\n      Output JSON strictly as:\n      {\n        \"holdings\": [\n          {\n            \"ticker\": \"AAPL\",\n            \"weight\": 0.08,\n            \"sector\": \"Information Technology\",\n            \"theme\": null,\n            \"rationale\": \"High composite score (0.75), strong sentiment, sector leader\",\n            \"composite_score\": 0.75\n          },\n          ... exactly 20 holdings ...\n        ]\n      }",
  "llm_response": {
    "holdings": [
      {
        "ticker": "ADBE",
        "weight": 0.1,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Highest composite score (0.686), strong market position.",
        "composite_score": 0.686
      },
      {
        "ticker": "GOOGL",
        "weight": 0.09,
        "sector": "Communication Services",
        "theme": "AI Infrastructure Buildout",
        "rationale": "Strong growth in AI, high investor confidence.",
        "composite_score": 0.655
      },
      {
        "ticker": "MRK",
        "weight": 0.08,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Positive revenue growth outlook, strong dividend increase.",
        "composite_score": 0.64
      },
      {
        "ticker": "V",
        "weight": 0.08,
        "sector": "Financials",
        "theme": null,
        "rationale": "Strong analyst sentiment and market position in digital payments.",
        "composite_score": 0.609
      },
      {
        "ticker": "BKNG",
        "weight": 0.07,
        "sector": "Consumer Discretionary",
        "theme": null,
        "rationale": "Resilient performance in travel sector, strong recovery potential.",
        "composite_score": 0.58
      },
      {
        "ticker": "NDAQ",
        "weight": 0.07,
        "sector": "Financial Services",
        "theme": "Energy Transition and Sustainability",
        "rationale": "Proactive financial management and strong stock performance.",
        "composite_score": 0.585
      },
      {
        "ticker": "MA",
        "weight": 0.06,
        "sector": "Financials",
        "theme": null,
        "rationale": "Strong cash generation and commitment to shareholder returns.",
        "composite_score": 0.584
      },
      {
        "ticker": "AMGN",
        "weight": 0.06,
        "sector": "Biotechnology",
        "theme": "Healthcare and Biotech Innovation",
        "rationale": "FDA approval for new therapy enhances growth prospects.",
        "composite_score": 0.508
      },
      {
        "ticker": "JPM",
        "weight": 0.05,
        "sector": "Financials",
        "theme": null,
        "rationale": "Innovative growth plans and strong market sentiment.",
        "composite_score": 0.515
      },
      {
        "ticker": "PFE",
        "weight": 0.05,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Strategic partnerships and ongoing research advancements.",
        "composite_score": 0.378
      },
      {
        "ticker": "NFLX",
        "weight": 0.05,
        "sector": "Communication Services",
        "theme": "Regulatory Changes in Technology and Trade",
        "rationale": "Strong long-term performance and commitment to theatrical releases.",
        "composite_score": 0.406
      },
      {
        "ticker": "CSCO",
        "weight": 0.04,
        "sector": "Information Technology",
        "theme": "Regulatory Changes in Technology and Trade",
        "rationale": "Strong demand in AI infrastructure and positive market outlook.",
        "composite_score": 0.411
      },
      {
        "ticker": "ISRG",
        "weight": 0.04,
        "sector": "Health Care",
        "theme": "Healthcare and Biotech Innovation",
        "rationale": "Expansion of robotic surgery capabilities enhances market position.",
        "composite_score": 0.404
      },
      {
        "ticker": "TROW",
        "weight": 0.03,
        "sector": "Financials",
        "theme": null,
        "rationale": "New strategic initiatives despite recent outflows.",
        "composite_score": 0.468
      },
      {
        "ticker": "UNH",
        "weight": 0.03,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Resilience amid challenges, potential for future growth.",
        "composite_score": 0.282
      },
      {
        "ticker": "BMY",
        "weight": 0.02,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Positive outlook following rating upgrade and pipeline catalysts.",
        "composite_score": 0.244
      },
      {
        "ticker": "GILD",
        "weight": 0.02,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Promising advancements in product pipeline despite challenges.",
        "composite_score": 0.307
      },
      {
        "ticker": "NTRS",
        "weight": 0.02,
        "sector": "Financials",
        "theme": null,
        "rationale": "Strong business momentum and competitive lending strategy.",
        "composite_score": 0.332
      },
      {
        "ticker": "PEP",
        "weight": 0.02,
        "sector": "Consumer Staples",
        "theme": null,
        "rationale": "Strong dividend aristocrat with positive investor sentiment.",
        "composite_score": 0.331
      },
      {
        "ticker": "VZ",
        "weight": 0.02,
        "sector": "Communication Services",
        "theme": null,
        "rationale": "Disciplined approach to pricing and focus on customer service.",
        "composite_score": 0.356
      }
    ]
  },
  "model": "gpt-4o-mini",
  "timestamp": "2025-12-16T07:26:46.780265"
}